Clinical Utility of Rush Venom Immunotherapy: Current Status
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s200917
Abstract: Abstract Hymenoptera venom allergy (HVA) is the leading cause of anaphylactic reactions in adults and the second most common cause in children. Venom immunotherapy (VIT) is used to elicit an immune tolerance against hymenoptera venom… read more here.
Keywords: clinical utility; utility rush; rush venom; venom ... See more keywords